Clinical Trial Update: Safety of Simvastatin in LAM and TSC [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial reported on the safety of simvastatin in patients with Lymphangioleiomyomatosis and Tuberous Sclerosis Complex; study completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphangioleiomyomatosis
• Tuberous Sclerosis Complex

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: University of Pennsylvania | Conditions: Lymphangioleiomyomatosis, Tuberous Sclerosis Complex | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-08-25